Cancer cells survive by manipulating direct
interactions with other cells, but they thrive
by changing the environment they live in.
This tumor microenvironment (TME) favors
cancer cell survival and protects against
antagonists, making it a major obstacle for
many potential therapeutic approaches.
A greater understanding of the TME will
enable scientists to manipulate it to create
an environment more amenable to anti-
cancer strategies.
- M. Rajabi, S.A. Mousa, “The role of angiogenesis in cancer treatment,” Biomedicines,
5(2):34, 2017. - L. Yadav et al., “Tumour angiogenesis and angiogenic inhibitors: a review,” J Clin Diagn
Res, 9(6): XE01-XE05, 2015. - G. Lupo et al., “Anti-angiogenic therapy in cancer: downsides and new pivots for
precision medicine,” Front Pharmacol, 7:519, 2016. - S. Spranger, T. F. Gajewski, “Mechanisms of tumor cell-intrinsic immune evasion,” Annu
Rev Cancer Biol, 2:1,213-28, 2018. - J. Cheng et al., “Understanding the mechanisms of resistance to CAR T-cell therapy in
malignancies,” Front Oncol, 9:1237, 2019.
6. P. Darvin et al., “Immune checkpoint inhibitors: recent progress and potential
biomarkers,” Exp Mol Med, 50:165, 2018
7. K.E. Allison et al., “Metabolic reprogramming in the tumour microenvironment:
a hallmark shared by cancer cells and T lymphocytes,” Immunology, 152(2):175-84, 2017.
8. V. Gouirand et al., “Influence of the tumor microenvironment on cancer cells metabolic
reprogramming,” Front Oncol, 8:117, 2018.
9. L. Sun et al., “Metabolic reprogramming for cancer cells and their microenvironment:
beyond the Warburg Effect,” Biochim Biophys Acta Rev Cancer, 1870(1):51-66, 2018.
10. A. Luengo et al., “Targeting metabolism for cancer therapy,” Cell Chem Biol,
24(9):1161-80, 2017.
11. B. Wegiel et al., “Metabolic switch in the tumor microenvironment determines immune
responses to anti-cancer therapy,” Front Oncol, 8:284, 2018.
12. V.M. Ngwa et al., “Microenvironmental metabolism regulates antitumor immunity,”
Cancer Res, 79(16):4003-8, 2019.
13. V.M. Youngblood et al., “The Ephrin-A1/EPHA2 signaling axis regulates glutamine
metabolism in HER2-positive breast cancer,” Cancer Res, 76:1825-36, 2016.
14. E. Shiuan, J. Chen, “Eph receptor tyrosine kinases in tumor immunity,” Cancer Res,
76:6452-7, 2016.
15. S.R. Pillai et al., “Causes, consequences, and therapy of tumors acidosis,” Cancer
Metastasis Rev, 38:205-22, 2019.
ReferencesReferences
thethethethe Secrets Secrets Secrets Secrets of of the the Tumor Tumor Tumor Tumor Tumor Tumor Tumor Tumor
MicroenvironmentMicroenvironmentMicroenvironmentMicroenvironment
forforforfor Cancer Cancer Cancer Cancer Therapeutics Therapeutics Therapeutics Therapeutics Therapeutics Therapeutics